COMMNETs/NANETS Guidelines for the diagnosis & management of patients with Lung NeuroEndocrine Tumours

“Lung neuroendocrine tumors (LNETs) are uncommon cancers and there is a paucity of randomized evidence to guide practice. As a result, current guidelines from different neuroendocrine tumor societies vary considerably. There is a need to update and harmonise global consensus guidelines. This paper reports best practice guidelines produced by a collaboration between the Commonwealth Neuroendocrine Tumour Research Collaboration (CommNETs) and the North American Neuroendocrine Tumor Society (NANETS).”

Share this post

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Subscribe to our eNews

Stay up to date on news and events, clinical trials and new research on neuroendocrine cancers.

Recent posts

Related Posts


During May, Patient Voice Initiative are  running free webinars for patients, the topics are: Friday 14 May – Clinical trials and the patient voice How